Short pages
Jump to navigation
Jump to search
Showing below up to 50 results in range #7,961 to #8,010.
- (hist) Alagille syndrome epidemiology and demographics [245 bytes]
- (hist) Mental retardation-nasal hypoplasia-obesity-genital hypoplasia [245 bytes]
- (hist) Porphyria other diagnostic studies [245 bytes]
- (hist) Porphyria primary prevention [245 bytes]
- (hist) Secondary adrenal insufficiency case study one [245 bytes]
- (hist) Synovial sarcoma secondary prevention [245 bytes]
- (hist) Dermatofibroma cost-effectiveness of therapy [245 bytes]
- (hist) Diabetic neuropathy electrocardiogram [245 bytes]
- (hist) Hyperaldosteronism electrocardiogram [245 bytes]
- (hist) Premature ovarian failure epidemiology and demographics [245 bytes]
- (hist) Premature ovarian failure cost-effectiveness of therapy [245 bytes]
- (hist) Phosphate nephropathy pathophysiology [245 bytes]
- (hist) Phosphate nephropathy causes [245 bytes]
- (hist) Phosphate nephropathy differential diagnosis [245 bytes]
- (hist) Phosphate nephropathy epidemiology and demographics [245 bytes]
- (hist) Phosphate nephropathy risk factors [245 bytes]
- (hist) Phosphate nephropathy natural history, complications and prognosis [245 bytes]
- (hist) Phosphate nephropathy diagnostic criteria [245 bytes]
- (hist) Phosphate nephropathy history and symptoms [245 bytes]
- (hist) Phosphate nephropathy physical examination [245 bytes]
- (hist) Phosphate nephropathy laboratory findings [245 bytes]
- (hist) Phosphate nephropathy biopsy [245 bytes]
- (hist) Phosphate nephropathy x ray [245 bytes]
- (hist) Phosphate nephropathy ultrasound [245 bytes]
- (hist) Phosphate nephropathy other diagnostic studies [245 bytes]
- (hist) Phosphate nephropathy medical therapy [245 bytes]
- (hist) Phosphate nephropathy surgery [245 bytes]
- (hist) Phosphate nephropathy primary prevention [245 bytes]
- (hist) Phosphate nephropathy secondary prevention [245 bytes]
- (hist) Phosphate nephropathy cost-effectiveness of therapy [245 bytes]
- (hist) Phosphate nephropathy future or investigational therapies [245 bytes]
- (hist) Phosphate nephropathy case study one [245 bytes]
- (hist) Gallbladder polyp causes [245 bytes]
- (hist) Hepatotoxicity primary prevention [245 bytes]
- (hist) Taenia infection case study one [245 bytes]
- (hist) Taenia infection future or investigational therapies [245 bytes]
- (hist) Taenia infection cost-effectiveness of therapy [245 bytes]
- (hist) Taenia infection physical examination [245 bytes]
- (hist) Taenia infection causes [245 bytes]
- (hist) Taenia infection other diagnostic studies [245 bytes]
- (hist) Taenia infection surgery [245 bytes]
- (hist) Taenia infection classification [245 bytes]
- (hist) Penicillin V potassium contraindications [245 bytes]
- (hist) Sandbox/algorithm [245 bytes]
- (hist) Palla's sign [245 bytes]
- (hist) Graft-versus-host disease secondary prevention [245 bytes]
- (hist) Cholesterolosis of gallbladder epidemiology and demographics [245 bytes]
- (hist) Overweight natural history, complications and prognosis [245 bytes]
- (hist) Cryptosporidiosis CT [245 bytes]
- (hist) Neurosyphilis Electrocardiogram [245 bytes]